KPNA3
Basic information
Region (hg38): 13:49699320-49792682
Links
Phenotypes
GenCC
Source:
- spastic paraplegia 88, autosomal dominant (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 88, autosomal dominant | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 34564892; 34825409; 34981581 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KPNA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 2 | 13 | 2 | 1 |
Variants in KPNA3
This is a list of pathogenic ClinVar variants found in the KPNA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-49702390-T-G | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
13-49702435-A-G | Spastic paraplegia 88, autosomal dominant | Uncertain significance (Sep 22, 2024) | ||
13-49702470-T-G | Inborn genetic diseases | Uncertain significance (Feb 15, 2023) | ||
13-49705729-C-A | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
13-49705773-A-C | Spastic paraplegia 88, autosomal dominant | Pathogenic (Nov 02, 2022) | ||
13-49706276-G-C | Inborn genetic diseases | Uncertain significance (Apr 18, 2023) | ||
13-49706289-C-T | Spastic paraplegia 88, autosomal dominant | Uncertain significance (Feb 14, 2024) | ||
13-49706324-C-T | Uncertain significance (Dec 30, 2022) | |||
13-49706356-A-G | Spastic paraplegia 88, autosomal dominant | Pathogenic (Nov 02, 2022) | ||
13-49709576-T-G | not specified | Uncertain significance (Aug 14, 2023) | ||
13-49709598-A-T | Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
13-49709603-A-C | Spastic paraplegia 88, autosomal dominant | Pathogenic (Nov 02, 2022) | ||
13-49709621-A-G | Spastic paraplegia 88, autosomal dominant | Pathogenic (Nov 02, 2022) | ||
13-49709659-G-A | Likely benign (Mar 01, 2024) | |||
13-49709660-G-A | Spastic paraplegia 88, autosomal dominant | Likely pathogenic (Mar 01, 2024) | ||
13-49709678-C-T | Inborn genetic diseases | Uncertain significance (May 28, 2024) | ||
13-49721985-A-T | Inborn genetic diseases | Uncertain significance (Mar 11, 2024) | ||
13-49722025-T-C | Likely pathogenic (Nov 01, 2022) | |||
13-49722055-C-T | Inborn genetic diseases | Likely benign (Mar 30, 2024) | ||
13-49722076-T-C | Inborn genetic diseases | Uncertain significance (May 21, 2024) | ||
13-49722533-C-T | Inborn genetic diseases | Likely benign (Sep 29, 2022) | ||
13-49725420-C-A | Spastic paraplegia 88, autosomal dominant | Uncertain significance (Apr 04, 2024) | ||
13-49725481-G-T | Inborn genetic diseases | Uncertain significance (Feb 05, 2024) | ||
13-49732392-T-C | Benign (Jan 01, 2023) | |||
13-49732764-G-C | Uncertain significance (Feb 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KPNA3 | protein_coding | protein_coding | ENST00000261667 | 17 | 93611 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.954 | 0.0464 | 125729 | 0 | 9 | 125738 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.39 | 110 | 266 | 0.414 | 0.0000125 | 3421 |
Missense in Polyphen | 25 | 116.03 | 0.21547 | 1511 | ||
Synonymous | -0.585 | 98 | 90.9 | 1.08 | 0.00000444 | 973 |
Loss of Function | 4.39 | 5 | 31.7 | 0.158 | 0.00000152 | 391 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000210 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000931 | 0.0000924 |
European (Non-Finnish) | 0.0000455 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non- classical NLS. Recognizes NLSs of influenza A virus nucleoprotein probably through ARM repeats 7-9.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Disease;NS1 Mediated Effects on Host Pathways;Host Interactions with Influenza Factors;Influenza Infection;Infectious disease;TNFalpha
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.476
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.89
Haploinsufficiency Scores
- pHI
- 0.708
- hipred
- Y
- hipred_score
- 0.748
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.831
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kpna3
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- NLS-bearing protein import into nucleus;modulation by virus of host process;viral entry into host cell;protein-containing complex assembly;viral penetration into host nucleus
- Cellular component
- nuclear pore;nucleoplasm;cytosol;host cell
- Molecular function
- protein binding;protein C-terminus binding;nuclear localization sequence binding;protein transporter activity;nuclear import signal receptor activity